Drug · DIN 02229293
ENTOCORT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 13, 2016; first marketed January 30, 1997.
- Drug Identification Number (DIN)
- 02229293
- Company (DIN owner)
- Tillotts Pharma GmbhRheinfelden, Baden-Wuerttemberg, Germany
- Schedule
- Prescription
- Dosage form
- Capsule (Sustained-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Budesonide A07EA06
- Class
- Human
- Record last updated
- July 15, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BUDESONIDE | 3 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 13, 2016: NOC 18270New Drug Submission (NDS) · Transfer of drug identification numbers
- February 15, 2000: NOC 1015New Drug Submission (NDS)
- August 15, 1996: NOC 4250Supplement to a New Drug Submission (SNDS) · New indication and new dosage form